Anti-myeloma immunotherapy using T-cells redirected by modified antibodies targeting NY-ESO-1

Masaki Maruta

Presentation information

Oral Session

Oral Session 1-5C MM: Immune pathology

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Naoki Hosen (Department of Cancer Seem Cell Biology, Osaka University Grad Sch. Med., Japan)

[OS1-5C-6] Anti-myeloma immunotherapy using T-cells redirected by modified antibodies targeting NY-ESO-1

Masaki Maruta¹, Toshiki Ochi¹, Kazushi Tanimoto¹, Taichi Azuma¹, Takashi Saitou², Hiroshi Fujiwara¹, Takeshi Imamura², Masaki Yasukawa¹ (1.Dept. of Hematology, Clinical Immunology and Infectious Disease, Ehime Univ., 2.Div. of Bio-Imaging, Proteo-Science Center, Ehime University)

Abstract password authentication.
Password is written on a program and abstract book.